| Issue Date | Title | Author(s) |
| 2011-01 | Cellular release profiling of controlled release dry powder pulmonary formulation | Ong, HX; Traini, D; Bebawy, M; Young, P; Dalby, RN; Byron, PR; Peart, J; Suman, JD; Young, PM |
| 2010-01 | Characterization of P-gp Expression and Function vs. Time and Passage in the Calu-3 Air-Interface Model for Drug Delivery to the Lung | Haghi, M; Young, P; Traini, D; Bebawy, M; Dalby, RN; Byron, PR; Peart, J; Suman, JD; Farr, SJ; Young, PM |
| 2011-01 | Comparison of albuterol sulphate and base dry powder particulate deposition using the Calu-3 lung epithelial model | Haghi, M; Traini, D; Bebawy, M; Young, P; Dalby, RN; Byron, PR; Peart, J; Suman, JD; Young, PM |
| 2021-01-01 | Genetic and Pharmacological Studies Reveal Acid Sensing Ion Channel 1a as a Novel Therapeutic Target Against Cardiac Ischaemia-Reperfusion Injury | Redd, M; Scheuer, S; Saez, N; Yoshikawa, Y; Chiu, H; Gao, L; Hicks, M; Villanueva, J; Cuellar-Partida, G; Peart, J; Hoe, LS; Chen, X; Sun, Y; Suen, J; Hatch, R; Rollo, B; Alzubaidi, M; Maljevic, S; Quaife-Ryan, G; Hudson, J; Porrello, E; White, M; Cordwell, S; Fraser, J; Petrou, S; Reichelt, M; Thomas, W; King, G; Macdonald, P; Palpant, N |
| 2012-01 | Inhaled Liposomal Ciprofloxacin Nanoparticles Control the Release of Antibiotic at the Bronchial Epithelia | Ong, HX; Cipolla, DC; Gonda, I; Traini, D; Bebawy, M; Agus, H; Young, PM; Dalby, RN; Byron, PR; Peart, J; Suman, JD; Farr, SJ; Young, PM |
| 2014-01 | Optimization of RPMI 2650 Cells as a Model for Nasal Mucosa | Pozzoli, M; Sonvico, F; Ong, HX; Traini, D; Bebawy, M; Young, P; Dalby, RN; Byron, PR; Peart, J; Suman, JD; Farr, SJ; Young, PM; Traini, D |
